Quantcast

Lecture Series Focuses On Effects Of Protein Folding On Health And Drug Discoveries

March 3, 2011

Protein folding and how it affects disease and drug discovery will be the focus of lectures hosted Thursday, March 3, by The Verna and Marrs McLean Department of Biochemistry and Molecular Biology at Baylor College of Medicine in Houston.

Guest speakers will include Dr. David S. Eisenberg, director of the University of California at Los Angeles Department of Energy Institute for Genomics and Proteomics, and Sir Tom Blundell, Ph.D., director of research and professor emeritus in the department of biochemistry at the University of Cambridge.

Eisenberg, whose research focuses on protein folding and how it relates to neurological disorders in humans, will give a lecture titled, “The Amyloid State of Proteins in Health and Disease.” Blundell, who believes the understanding of the architecture of protein assemblies can assist the discovery of new medicines, will give a lecture titled, “Genomes, Structural Biology and Drug Discovery.”

The lecture series, which is free and open to the public, will be held in the main auditorium of the Cullen Building at BCM. Eisenberg’s lecture will begin at 2 p.m. and Blundell’s will begin at 3:30 p.m. with a 30-minute reception between lectures.

Named for philanthropists Verna and Marrs McLean, the lecture series was started in 1972 by Dr. Salih J. Wakil, professor and chair emeritus of biochemistry at BCM, to honor the family’s generous support of the department.

On the Net:




comments powered by Disqus